251 related articles for article (PubMed ID: 28942086)
1. Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study.
Herazo-Maya JD; Sun J; Molyneaux PL; Li Q; Villalba JA; Tzouvelekis A; Lynn H; Juan-Guardela BM; Risquez C; Osorio JC; Yan X; Michel G; Aurelien N; Lindell KO; Klesen MJ; Moffatt MF; Cookson WO; Zhang Y; Garcia JGN; Noth I; Prasse A; Bar-Joseph Z; Gibson KF; Zhao H; Herzog EL; Rosas IO; Maher TM; Kaminski N
Lancet Respir Med; 2017 Nov; 5(11):857-868. PubMed ID: 28942086
[TBL] [Abstract][Full Text] [Related]
2. Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study.
Scott MKD; Quinn K; Li Q; Carroll R; Warsinske H; Vallania F; Chen S; Carns MA; Aren K; Sun J; Koloms K; Lee J; Baral J; Kropski J; Zhao H; Herzog E; Martinez FJ; Moore BB; Hinchcliff M; Denny J; Kaminski N; Herazo-Maya JD; Shah NH; Khatri P
Lancet Respir Med; 2019 Jun; 7(6):497-508. PubMed ID: 30935881
[TBL] [Abstract][Full Text] [Related]
3. Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation.
Stuart BD; Lee JS; Kozlitina J; Noth I; Devine MS; Glazer CS; Torres F; Kaza V; Girod CE; Jones KD; Elicker BM; Ma SF; Vij R; Collard HR; Wolters PJ; Garcia CK
Lancet Respir Med; 2014 Jul; 2(7):557-65. PubMed ID: 24948432
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis.
Herazo-Maya JD; Noth I; Duncan SR; Kim S; Ma SF; Tseng GC; Feingold E; Juan-Guardela BM; Richards TJ; Lussier Y; Huang Y; Vij R; Lindell KO; Xue J; Gibson KF; Shapiro SD; Garcia JG; Kaminski N
Sci Transl Med; 2013 Oct; 5(205):205ra136. PubMed ID: 24089408
[TBL] [Abstract][Full Text] [Related]
5. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.
Peljto AL; Zhang Y; Fingerlin TE; Ma SF; Garcia JG; Richards TJ; Silveira LJ; Lindell KO; Steele MP; Loyd JE; Gibson KF; Seibold MA; Brown KK; Talbert JL; Markin C; Kossen K; Seiwert SD; Murphy E; Noth I; Schwarz MI; Kaminski N; Schwartz DA
JAMA; 2013 Jun; 309(21):2232-9. PubMed ID: 23695349
[TBL] [Abstract][Full Text] [Related]
6. 50-gene risk profiles in peripheral blood predict COVID-19 outcomes: A retrospective, multicenter cohort study.
Juan Guardela BM; Sun J; Zhang T; Xu B; Balnis J; Huang Y; Ma SF; Molyneaux PL; Maher TM; Noth I; Michaud G; Jaitovich A; Herazo-Maya JD
EBioMedicine; 2021 Jul; 69():103439. PubMed ID: 34157486
[TBL] [Abstract][Full Text] [Related]
7. Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis.
Makiguchi T; Yamada M; Yoshioka Y; Sugiura H; Koarai A; Chiba S; Fujino N; Tojo Y; Ota C; Kubo H; Kobayashi S; Yanai M; Shimura S; Ochiya T; Ichinose M
Respir Res; 2016 Sep; 17(1):110. PubMed ID: 27596748
[TBL] [Abstract][Full Text] [Related]
8. A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis.
Huang Y; Ma SF; Vij R; Oldham JM; Herazo-Maya J; Broderick SM; Strek ME; White SR; Hogarth DK; Sandbo NK; Lussier YA; Gibson KF; Kaminski N; Garcia JG; Noth I
BMC Pulm Med; 2015 Nov; 15():147. PubMed ID: 26589497
[TBL] [Abstract][Full Text] [Related]
9. BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis.
Prasse A; Binder H; Schupp JC; Kayser G; Bargagli E; Jaeger B; Hess M; Rittinghausen S; Vuga L; Lynn H; Violette S; Jung B; Quast K; Vanaudenaerde B; Xu Y; Hohlfeld JM; Krug N; Herazo-Maya JD; Rottoli P; Wuyts WA; Kaminski N
Am J Respir Crit Care Med; 2019 Mar; 199(5):622-630. PubMed ID: 30141961
[TBL] [Abstract][Full Text] [Related]
10. Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials.
Durheim MT; Collard HR; Roberts RS; Brown KK; Flaherty KR; King TE; Palmer SM; Raghu G; Snyder LD; Anstrom KJ; Martinez FJ;
Lancet Respir Med; 2015 May; 3(5):388-96. PubMed ID: 25890798
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real-world multicentre cohort.
Durheim MT; Bendstrup E; Carlson L; Sutinen EM; Hyldgaard C; Kalafatis D; Myllärniemi M; Sköld CM; Sjåheim T
Respirology; 2021 Oct; 26(10):982-988. PubMed ID: 34291523
[TBL] [Abstract][Full Text] [Related]
12. Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis.
Tzouvelekis A; Herazo-Maya JD; Slade M; Chu JH; Deiuliis G; Ryu C; Li Q; Sakamoto K; Ibarra G; Pan H; Gulati M; Antin-Ozerkis D; Herzog EL; Kaminski N
Respirology; 2017 Apr; 22(3):486-493. PubMed ID: 27761978
[TBL] [Abstract][Full Text] [Related]
13. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.
Huet S; Tesson B; Jais JP; Feldman AL; Magnano L; Thomas E; Traverse-Glehen A; Albaud B; Carrère M; Xerri L; Ansell SM; Baseggio L; Reyes C; Tarte K; Boyault S; Haioun C; Link BK; Feugier P; Lopez-Guillermo A; Tilly H; Brice P; Hayette S; Jardin F; Offner F; Sujobert P; Gentien D; Viari A; Campo E; Cerhan JR; Salles G
Lancet Oncol; 2018 Apr; 19(4):549-561. PubMed ID: 29475724
[TBL] [Abstract][Full Text] [Related]
14. Investigation of a Hypoxia-Immune-Related Microenvironment Gene Signature and Prediction Model for Idiopathic Pulmonary Fibrosis.
Li X; Cai H; Cai Y; Zhang Q; Ding Y; Zhuang Q
Front Immunol; 2021; 12():629854. PubMed ID: 34194423
[TBL] [Abstract][Full Text] [Related]
15. Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis.
Oldham JM; Huang Y; Bose S; Ma SF; Kim JS; Schwab A; Ting C; Mou K; Lee CT; Adegunsoye A; Ghodrati S; Pugashetti JV; Nazemi N; Strek ME; Linderholm AL; Chen CH; Murray S; Zemans RL; Flaherty KR; Martinez FJ; Noth I
Am J Respir Crit Care Med; 2024 May; 209(9):1111-1120. PubMed ID: 37847691
[No Abstract] [Full Text] [Related]
16. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
[TBL] [Abstract][Full Text] [Related]
17. Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis.
Aggarwal R; McBurney C; Schneider F; Yousem SA; Gibson KF; Lindell K; Fuhrman CR; Oddis CV
Rheumatology (Oxford); 2017 Mar; 56(3):384-389. PubMed ID: 28082622
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study.
Wells JM; Farris RF; Gosdin TA; Dransfield MT; Wood ME; Bell SC; Rowe SM
Lancet Respir Med; 2016 Aug; 4(8):636-645. PubMed ID: 27298019
[TBL] [Abstract][Full Text] [Related]
19. [
Justet A; Laurent-Bellue A; Thabut G; Dieudonné A; Debray MP; Borie R; Aubier M; Lebtahi R; Crestani B
Respir Res; 2017 Apr; 18(1):74. PubMed ID: 28449678
[TBL] [Abstract][Full Text] [Related]
20. An 8-ferroptosis-related genes signature from Bronchoalveolar Lavage Fluid for prognosis in patients with idiopathic pulmonary fibrosis.
He Y; Shang Y; Li Y; Wang M; Yu D; Yang Y; Ning S; Chen H
BMC Pulm Med; 2022 Jan; 22(1):15. PubMed ID: 34983465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
